ITP
Iron Triangle Partners’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.4M | Buy |
249,997
+57,178
| +30% | +$10.6M | 7.13% | 3 |
|
|
2025
Q1 | $40.4M | Sell |
192,819
-181,193
| -48% | -$38M | 6.37% | 3 |
|
|
2024
Q4 | $66.5M | Buy |
+374,012
| New | +$66.5M | 7.32% | 3 |
|
|
2024
Q3 | – | Sell |
-284,657
| Closed | -$48.8M | – | 25 |
|
|
2024
Q2 | $48.8M | Buy |
284,657
+8,559
| +3% | +$1.47M | 4.96% | 9 |
|
|
2024
Q1 | $50.3M | Buy |
276,098
+26,098
| +10% | +$4.75M | 5.15% | 4 |
|
|
2023
Q4 | $38.7M | Hold |
250,000
| – | – | 5.01% | 7 |
|
|
2023
Q3 | $37.3M | Sell |
250,000
-200,000
| -44% | -$29.8M | 5.45% | 7 |
|
|
2023
Q2 | $60.6M | Buy |
450,000
+130,000
| +41% | +$17.5M | 8.1% | 3 |
|
|
2023
Q1 | $51M | Buy |
+320,000
| New | +$51M | 7.36% | 2 |
|
|
2022
Q3 | – | Sell |
-350,000
| Closed | -$53.6M | – | 28 |
|
|
2022
Q2 | $53.6M | Buy |
350,000
+110,000
| +46% | +$16.8M | 6.95% | 1 |
|
|
2022
Q1 | $38.9M | Sell |
240,000
-10,000
| -4% | -$1.62M | 4.63% | 7 |
|
|
2021
Q4 | $33.9M | Sell |
250,000
-143,024
| -36% | -$19.4M | 4.72% | 9 |
|
|
2021
Q3 | $42.4M | Sell |
393,024
-139,499
| -26% | -$15M | 6.08% | 6 |
|
|
2021
Q2 | $60M | Buy |
532,523
+232,523
| +78% | +$26.2M | 6.18% | 4 |
|
|
2021
Q1 | $32.5M | Buy |
+300,000
| New | +$32.5M | 4.13% | 11 |
|